Sourcing:

Arcadia's intimate knowledge of the pharmaceutical industry gives it an excellent edge in API and intermediate sourcing. Our approach is to act as a client's purchase team in China ensuring supplies at the optimum price. We have also been involved in securing exclusive deals and differential pricing for our clients to give them a sustainable cost edge in the market. We obviously have a differentiated approach for the regulated and non-regulated markets which is elaborated below:

Less regulated market:
Arcadia ensures that the API/intermediate is sourced from the most competitive manufacturer, not only in terms of price, but also from the point of view of sustainable competitiveness. This is done through a thorough analysis of the competition, route of synthesis and vertical integration of the manufactures. We have successfully rooted out traders from our client's vendor list and replaced them with medium scale quality manufacturers. We have also been heavily involved in sourcing specialty/new API/intermediate for our client base.

Regulated markets:
Arcadia has been involved in strategizing the entire API basket for clients and has successfully optimized API procurement to deliver a cost edge in the market. Our specialization lies in identifying medium scale quality manufacturers and hand holding them through the entire regulatory cycle to get them US FDA approvals. In return, we get them rock bottom prices and assured deliveries.